Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure

AtheroNova Inc. (AHRO) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/03/2015 8-K Form 8-K - Current report
02/19/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "AtheroNova Receives Additional Notices of Debt Acceleration"
02/13/2015 8-K Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran...
12/09/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/20/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/31/2014 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Form of Warrant Agency Agreement, by and between AtheroNova Inc. and Securities Transfer Corporation and Form of Warrant Certificate"
09/15/2014 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Securities Purchase Agreement, among AtheroNova Inc., the purchasers of 8% Senior Secured Convertible Notes and W-Net Fund I, L.P., as Purchaser Representative",
"Form of 8% Senior Secured Convertible Note",
"Form of Common Stock Purchase Warrant",
"Security Agreement, among AtheroNova Inc., AtheroNova Operations, Inc. and the purchasers of 8% Senior Secured Convertible Notes",
"Intellectual Property Security Agreement, among AtheroNova Inc., AtheroNova Operations, Inc. and the purchasers of 8% Senior Secured Convertible Notes",
"Subsidiary Guaranty, made by AtheroNova Operations, Inc. in favor of the purchasers of 8% Senior Secured Convertible Notes"
05/16/2014 8-K Unregistered Sales of Equity Securities
05/13/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/22/2014 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "ATHERONOVA 1-FOR-10 REVERSE STOCK SPLIT EFFECTIVE"
04/04/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/19/2014 8-K/A Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
01/21/2014 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
08/13/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "AtheroNova Inc. Company Presentation"
07/11/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "AtheroNova Inc. Company Presentation"
06/25/2013 8-K Form 8-K - Current report
05/08/2013 8-K/A Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
03/29/2013 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
01/23/2013 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "AtheroNova Inc. Investor Presentation"
12/06/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "First Amendment to Employment Agreement and effective August 29, 2012, between AtheroNova Inc. and Mark Selawski"
11/08/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AtheroNova Names New Director Fred Knoll of Knoll Capital Management Joins the Board of Directors IRVINE, Calif., Nov. 7, 2012 /PRNewswire/ -- AtheroNova Inc. , a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that Fred Knoll, the principal and portfolio manager of Knoll Capital Management, has been named to the Board of Directors of AtheroNova Inc. “As a leading investment manager, Fred brings a wealth of knowledge in emerging growth companies and will bring his expertise to our many opportunities as we transition into the next phase of clinical development at AtheroNova,” stated Thomas W. Gardner, CEO of AtheroNova. “We welcome Fred to our Board and look forward to working..."
10/17/2012 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
10/05/2012 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of Subscription Agreement",
"Form of Common Stock Purchase Warrant"
09/11/2012 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "AtheroNova Inc. Investor Presentation"
07/11/2012 8-K Form 8-K - Current report
06/20/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Form of Amendment and Exchange Agreement",
"Form of Second Amended and Restated 2.5% Senior Secured Convertible Note",
"Form of Amended and Restated Common Stock Purchase Warrant",
"Office Lease between AtheroNova Inc. and TR Dupont Centre LLC"
01/04/2012 8-K Form 8-K - Current report
10/28/2011 8-K Form 8-K - Current report
10/27/2011 8-K Entry into a Material Definitive Agreement
09/13/2011 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "AtheroNova Inc. Investor Presentation"
09/09/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "AtheroNova and Maxwell Biotech Group Agree on Deal Terms to Develop New Atherosclerosis Drug Maxwell to Fund Clinical Trials, Become Equity Investor in AtheroNova, and License AHRO-001 for Russia"
07/21/2011 8-K Form 8-K - Current report
06/29/2011 8-K Form 8-K - Current report
02/28/2011 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy